Dr. Jayaratna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
625 Madison Ave
New York, NY 10022Phone+1 212-241-4812Fax+1 212-987-4675- Is this information wrong?
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2014 - 2016
- University of Southern California/LAC+USC Medical CenterResidency, Urology, 2009 - 2014
- University of Southern California/LAC+USC Medical CenterInternship, Surgery, 2008 - 2009
- Rutgers New Jersey Medical SchoolClass of 2008
Certifications & Licensure
- CA State Medical License 2010 - Present
- NY State Medical License 2016 - 2024
- TX State Medical License 2015 - 2019
- American Board of Urology Urology
Publications & Presentations
PubMed
- 3 citationsTCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer, , , , , , , , , , , , , , , > ;Molecular Cancer Research. 2020 Jun 1
- 8 citationsDevelopment of a model to predict prostate cancer at the apex (PCAP model) in patients undergoing robot-assisted radical prostatectomy.Shivaram Cumarasamy, Alberto Martini, Ugo Falagario, Zeynep Gul, Alp Tuna Beksac, Isuru Jayaratna, George K. Haines, Giuseppe Carrieri, Ash Tewari> ;World Journal of Urology. 2020 Apr 1
- 29 citationsDefining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic TestsUgo Falagario, Alp Tuna Beksac, Alberto Martini, Shivaram Cumarasamy, Akriti Gupta, Sonya Prasad, Hari Thulasidass, Qainat N. Shah, Isuru Jayaratna, Sara Lewis, Ardesh...> ;The Journal of Urology. 2019 Jun 7
- Join now to see all
Journal Articles
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesIsuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology
Authored Content
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018
Research History
- Urologic Oncology Research FellowGenomic research as part of the MD Anderson Bladder Cancer SPORE. Studied bladder cancer molecular subtypes using in vitro and xenograft in vivo models.2014 - 2015
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
- NYC Health + Hospitals / ElmhurstElmhurst, New York
- NYC Health + Hospitals / QueensJamaica, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: